CANADA LIFE ASSURANCE Co
InsurancePosition in GILD — Gilead Sciences, Inc.
CIK 1046192
WINNIPEG, A2
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$208,212,110
-$25,369,640 QoQ
Shares Held
1,648,030
-1.7% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#87
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $3,027,251,343 across 9 Drug Manufacturers - General names. GILD ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
640,845 | $768,648,782 | |
| 2 | JNJ |
Johnson & Johnson
|
2,438,843 | $619,392,956 | |
| 3 | ABBV |
AbbVie Inc.
|
1,761,265 | $443,204,724 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,816,256 | $361,888,896 | |
| 5 | AZN |
Astrazeneca PLC
|
1,526,363 | $289,428,952 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,648,030 | $208,212,110 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,765,830 | $159,367,124 | |
| 8 | PFE |
Pfizer Inc
|
6,258,004 | $150,692,736 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,212,110 | 1,648,030 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $233,581,750 | 1,675,983 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $206,797,384 | 1,684,841 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $250,396,908 | 2,255,828 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $246,969,355 | 2,227,558 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $246,035,468 | 2,195,765 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $193,668,853 | 2,096,664 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $181,849,546 | 2,169,007 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $146,279,333 | 2,132,041 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $132,511,887 | 1,809,036 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $144,830,650 | 1,787,812 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $136,184,565 | 1,817,248 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $139,539,396 | 1,810,554 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $134,317,477 | 1,618,868 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $135,048,402 | 1,573,074 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $121,823,129 | 1,974,763 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $124,133,455 | 2,008,307 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $120,596,584 | 2,028,538 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $139,225,899 | 1,917,448 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $119,639,080 | 1,712,800 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $116,291,869 | 1,688,816 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $118,869,564 | 1,839,232 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $127,131,474 | 2,182,140 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $131,256,307 | 2,077,169 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $160,076,131 | 2,080,532 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $163,745,779 | 2,190,286 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||